| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 19, 2023 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 16,251 | $20.59 | $334,542.10 | -2.4% | -10.1% | +25.8% | |
| Dec 18, 2023 | A Agilent Technologies, Inc. | Gonsalves Rodney65 | V.p., Corporate Controller | Sell | 1,500 | $137.69 | $206,538.00 | -5.4% | +6.2% | -0.8% | |
| Dec 18, 2023 | WGS Genedx Holdings Corp. | Feeley Kevin46 | Chief Financial Officer | Sell | 2,948 | $2.16 | $6,365.91 | -11.3% | +425.0% | +4204.3% | |
| Dec 18, 2023 | WGS Genedx Holdings Corp. | Stueland Katherine | Chief Executive Officer | Sell | 11,734 | $2.16 | $25,338.40 | -18.2% | +425.0% | +4204.3% | |
| Dec 18, 2023 | WGS Genedx Holdings Corp. | Saad Kareem61 | Chief Transformation Officer | Sell | 1,700 | $2.16 | $3,670.98 | -6.6% | +425.0% | +4204.3% | |
| Dec 15, 2023 | PSNL Personalis, Inc. | Moore Stephen Michael52 | General Counsel | Sell | 1,476 | $1.47 | $2,169.72 | -1.9% | +4.6% | +153.0% | |
| Dec 15, 2023 | PSNL Personalis, Inc. | Chen Richard70 | Chief Medical Officer And EVP | Sell | 4,708 | $1.47 | $6,920.76 | -3.5% | +4.6% | +153.0% | |
| Dec 15, 2023 | PSNL Personalis, Inc. | Tachibana Aaron68 | CFO And COO | Sell | 6,747 | $1.47 | $9,918.09 | -3.5% | +4.6% | +153.0% | |
| Dec 15, 2023 | A Agilent Technologies, Inc. | Ancher-Jensen Henrik49 | Sr Vice President | Sell | 26,331 | $138.36 | $3,643,157.16 | -24.2% | +6.2% | +1.6% | |
| Dec 15, 2023 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 23,950 | $20.75 | $496,966.70 | -2.2% | -3.8% | +43.8% | |
| Dec 15, 2023 | MEDP Medpace Holdings, Inc. | Burwig Susan E64 | Exec. VP, Operations | Sell | 12,400 | $303.96 | $3,769,149.65 | -27.6% | +35.1% | +15.5% | |
| Dec 14, 2023 | NOTV Inotiv, Inc. | Beattie John Gregory | Chief Operating Officer | Buy | 47,966 | $3.12 | $149,836.19 | +75.2% | +167.1% | +91.9% | |
| Dec 14, 2023 | NOTV Inotiv, Inc. | Garrett Michael | Chief Commercial Officer | Buy | 5,000 | $2.83 | $14,145.00 | +43.6% | +167.1% | +91.9% | |
| Dec 14, 2023 | CRL Charles River Laboratories International, Inc. | Creamer Victoria L65 | EVP &Chief People Officer | Sell | 5,526 | $225.00 | $1,243,350.00 | -25.1% | +13.9% | -16.9% | |
| Dec 14, 2023 | EXAS Exact Sciences Corp | Condella Sarah75 | EVP, Human Resources | Sell | 2,000 | $70.00 | $140,000.00 | -2.7% | -9.9% | -9.7% | |
| Dec 13, 2023 | A Agilent Technologies, Inc. | McMullen Michael R.63 | CEO And President | Sell | 2,751 | $130.00 | $357,630.00 | -0.9% | +10.5% | +5.4% | |
| Dec 13, 2023 | NTRA Natera, Inc. | Healy James | Director | Sell | 644,000 | $58.75 | $37,835,000.00 | -100% | +51.1% | +177.0% | |
| Dec 13, 2023 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 8,432 | $20.19 | $170,250.72 | -1.1% | -2.9% | +41.7% | |
| Dec 13, 2023 | CSTL Castle Biosciences Inc | Bradbury Daniel69 | Director | Sell | 2,368 | $20.02 | $47,418.72 | -0.7% | -2.9% | +41.7% | |
| Dec 12, 2023 | BIO Bio-Rad Laboratories, Inc. | Wright Dara | EVP, President, Cdg | Sell | 1,200 | $299.16 | $358,992.00 | -44.5% | +16.8% | +15.9% | |
| Dec 11, 2023 | FLGT Fulgent Genetics, Inc. | Xie Jian77 | President And COO | Sell | 22,000 | $26.52 | $583,453.00 | -2.9% | -11.9% | -23.3% | |
| Dec 11, 2023 | WGS Genedx Holdings Corp. | Stueland Katherine | Chief Executive Officer | Sell | 3,673 | $1.61 | $5,915.00 | -7.5% | +452.4% | +4182.1% | |
| Dec 11, 2023 | WGS Genedx Holdings Corp. | Saad Kareem61 | Chief Transformation Officer | Sell | 850 | $1.61 | $1,368.84 | -4.0% | +452.4% | +4182.1% | |
| Dec 11, 2023 | WGS Genedx Holdings Corp. | Feeley Kevin46 | Chief Financial Officer | Sell | 908 | $1.61 | $1,462.24 | -4.6% | +452.4% | +4182.1% | |
| Dec 8, 2023 | NTRA Natera, Inc. | Marcus Gail Boxer | Director | Sell | 500 | $57.52 | $28,760.00 | -2.4% | +57.6% | +195.2% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.